Correction: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study (JMIR Formative Research (2022) 6:12 (e37144) DOI: 10.2196/37144)

Abstract

In “Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study” (JMIR Form Res 2022;6(12):e37144) the authors noted one error. In the originally published article Figure 6 appeared as a duplicate of Figure 5. Figure 6 has been corrected as follows: (Figure Presented) The correction version appeared in the online version of the paper on the JMIR Publications website on January 18, 2023. Because this was made after submission to full-text repositories, the corrected article has also been resubmitted to those repositories.